Delivery Order SPE2DB25D3022-SPE2DB25FWBQU
- Not listed
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is not subject to any set-aside designation and is scheduled for completion by September 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $24,945.90 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of July 15, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger procurement relationship with the federal government. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $12,554.90 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $27,596 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and is scheduled for completion by July 30, 2025. The vaccine product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $6,679 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, which is a child of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999 through December 2026), represents a competitively awarded, non-set-aside procurement with an ultimate completion date of October 21, 2025. Performance will take place at...
- The Defense Logistics Agency awarded a delivery order valued at $2,069.70 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on July 21, 2025, and the product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBQUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,449.50 on June 6, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill such federal medical supply requirements through open competition, combined with its extensive portfolio of vaccine and pharmaceutical deliveries, positions it as a critical vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/6/25 |